<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Agios Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Agios Pharmaceuticals, Inc.

    Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $542,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jacqualyn Fouse, Ph.D.
    • FOUNDED
      2008
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Nabriva Therapeutics plc

    Nabriva Therapeutics plc

    Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in th...

    Nabriva Therapeutics is a commercial-stage biop...

    Filing Type:    PU
    Deciphera Pharmaceuticals, Inc.

    Deciphera Pharmaceuticals, Inc.

    Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on...

    Deciphera Pharmaceuticals is a clinical-stage b...

    Filing Type:    PU
    AxoGen, Inc.

    AxoGen, Inc.

    Axogen (AXGN) is a global leader in innovative surgical solutions for peripheral n...

    Axogen (AXGN) is a global leader in innovative ...

    Filing Type:    PU
    CASI Pharmaceuticals, Inc.

    CASI Pharmaceuticals, Inc.

    CASI is a U.S. NASDAQ-listed biopharmaceutical company focused on developing and a...

    CASI is a U.S. NASDAQ-listed biopharmaceutical ...

    Filing Type:    PU
    CohBar, Inc.

    CohBar, Inc.

    CohBar, Inc. is a leader in the research and development of mitochondria based the...

    CohBar, Inc. is a leader in the research and de...

    Filing Type:    PU
    Checkpoint Therapeutics, Inc.

    Checkpoint Therapeutics, Inc.

    Checkpoint Therapeutics, Inc. (“Checkpoint”) is a clinical-stage, immuno-oncol...

    Checkpoint Therapeutics, Inc. (“Checkpoint”...

    Filing Type:    PU
    Nektar Therapeutics

    Nektar Therapeutics

    Nektar Therapeutics is a research-based development stage biopharmaceutical compan...

    Nektar Therapeutics is a research-based develop...

    Filing Type:    PU
    Cue Biopharma, Inc.

    Cue Biopharma, Inc.

    Cue Biopharma is an innovative clinical stage immunotherapy company developing a n...

    Cue Biopharma is an innovative clinical stage i...

    Filing Type:    PU
    Tyme Technologies, Inc.

    Tyme Technologies, Inc.

    Tyme Inc. is an emerging biotechnology company developing cancer therapeutics that...

    Tyme Inc. is an emerging biotechnology company ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.